Patients with pancreatic tumors had higher rates of positive somatostatin receptor imaging (SRI) (46%), lower values of Ki−67 (70% with Ki−67 < 55%) and longer overall survival, which could suggest the presence of NET G−3 in this population [33]. Here, MKI67 is linked to pancreatic neoplasm.